Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. HeraMED Limited
  6. Summary
    HMD   AU0000028367

HERAMED LIMITED

(HMD)
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
07/27/2021 07/28/2021 07/29/2021 07/30/2021 08/02/2021 Date
0.195 0.185 0.2 0.21 0.23 Last
1170135 407846 1533416 301149 506672 Volume
-2.50% -5.13% +8.11% +5.00% +9.52% Change
Estimated financial data (e) (USD)
Sales 2019 0,15 M - -
Net income 2019 -3,13 M - -
Net cash position 2019 1,84 M - -
P/E ratio 2019 -4,53x
Yield 2019 -
Sales 2020 0,04 M - -
Net income 2020 -3,36 M - -
Net cash position 2020 1,75 M - -
P/E ratio 2020 -4,12x
Yield 2020 -
Capitalization 31,3 M 31,3 M -
EV / Sales 2019 67,0x
EV / Sales 2020 277x
Nbr of Employees -
Free-Float 72,5%
More Financials
Company
Hera Med Ltd is an Israel-based company that develops pregnancy monitoring solutions for home and professional use. It offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetusÔÇÖ heart rate (FHR) at home. HeraBEAT communicates with... 
More about the company
All news about HERAMED LIMITED
07/18HERAMED : Obstetrix Medical Signs Deal for Integration of Maternity Care Platfor..
MT
07/18HeraMED Limited Announces Change of Registered Office
CI
07/18HeraMED Limited Announces Pilot Agreement with Obstetrix Medical Group
CI
05/13HERAMED : Enters Pilot Deal With US Clinical Services Provider
MT
05/12HeraMED Limited Announces Pilot Agreement with Obstetrix Medical Group
CI
04/22HERAMED : Signs Deal with Joondalup Health Campus for HeraCARE Platform; Shares ..
MT
04/21HeraMED Limited Announces Signed an Agreement with Joondalup Health Campus
CI
02/25Heramed Limited Reports Earnings Results for the Full Year Ended December 31,..
CI
02/08HERAMED : Israeli Hospital to Begin Pilot Study of HeraMED's Maternity Device, S..
MT
02/07HeraMED Limited Announces Sheba Medical Centre, Initiates Pilot to Test Both ..
CI
02/04HERAMED : Raises Nearly $2 Million via Share Placement; Shares Rise 11%
MT
01/27HERAMED : Secures Two-Year Subscription Extension from Brazilian Healthcare Grou..
MT
01/26Hapvida Extends its subscription for HeraCARE SaaS and cloud monitoring servi..
CI
2020HeraMED Limited Announces Mayo Clinic approves Clinical Study of HeraBEATTM t..
CI
2020HERAMED : Partners With Teleperinatal to Deploy HerCARE and HeraBEAT; Shares Up ..
MT
More news
News in other languages on HERAMED LIMITED
2019IRW-NEWS : Heramed Limited: Kooperationsvereinbarung unterzeichnet, um telemediz..
2019IRW-NEWS : Heramed Limited: HeraMED erhält FDA 510(k)-Genehmigung für das HeraBE..
2019IRW-NEWS : Heramed Limited: Update der Studie mit Hapvida Saude (Brasilien)
2019IRW-NEWS : Heramed Limited: HeraMED treibt Markteintritt von HeraBEAT und HeraCA..
2019IRW-NEWS : Heramed Limited: Abschluss einer Kooperationsvereinbarung mit IntMED ..
More news
Chart HERAMED LIMITED
Duration : Period :
HeraMED Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HERAMED LIMITED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Managers and Directors
David Groberman Chief Executive Officer, Director & MD
Sivan Sadan Chief Financial Officer
Ronald Peter Weinberger Non-Executive Chairman
Josef Tovbin Chief Medical Officer
Michael Nenner Chief Technology Officer
Sector and Competitors